Novartis Investigative Site

Culiacan Sinaloa 80230

0 studies enrolling now · 2 studies all time

What they study most

Cardiovascular Disease and Lipoprotein(a), Hypercholesterolemia

Studies at this site

• Assessing the Impact of Lipoprotein (a) Lowering With Pelacarsen (TQJ230) on Major Cardiovascular Events in Patients With CVD — Running, not enrolling
• Efficacy and Safety of Inclisiran as Monotherapy in Patients With Primary Hypercholesterolemia Not Receiving Lipid-lowering Therapy. — Completed